Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-11

AUTHORS

Marc C. Chamberlain, Donald Born

ABSTRACT

1p/19q codeletion is a favorable prognostic marker for oligodendroglial tumors (OT). Compare outcome in OT with simple deletions of 1p or 19q to those with relative deletions defined as the presence of both increased copy number (polysomy) and 1p/19q codeletion. 525 cases were examined by fluorescence in situ hybridization (FISH) using dual color probes to determine the deletion status of chromosome arms 1p and 19q. Categories included simple deletions defined as a proportion of either 1p32 or 19q13 FISH signals compared to 1q42 or 19p13 signals less than 0.80 and relative deletions (1p or 19q) defined as the combination of a <0.80 proportion with >30 % of nuclei showing increased chromosome number (based on enumeration of 1q25 or 19p13). 464 (80 %) were WHO Grade II or III OT of which 209 (48 %) had both 1p and 19q deleted (codeletion). 72 (16 %) had relative deletions for either one or both 1p and 19q of which 28 (6 %) had relative deletions of 1p and 19q (relative codeletion). Overall survival in WHO Grade II OT was 13 + years when 1p/19q codeleted (n = 156); 5 + years in uni- or nondeleted (n = 86); 6 + years in relative deletion for either 1p or 19q (n = 41); and 6 + years in relative 1p/19q codeletion (n = 15). Similarly in WHO Grade III OT (n = 168) overall survival was 11 + years in 1p/19q codeleted (n = 54) OT; 2.5 years in uni- or nondeleted (n = 70); 3 years in relative deletion for one or both 1p or 19q (n = 31); and 4 + years in relative 1p/19q codeletion (n = 13). Survival for OT regardless of grade with relative codeletion of 1p/19q was approximately one half that of 1p/19q codeleted tumors. The presence of relative 1p/19q codeletion is of prognostic significance. More... »

PAGES

249-251

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-015-1906-y

DOI

http://dx.doi.org/10.1007/s11060-015-1906-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009273335

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26341371


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosome Deletion", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosomes, Human, Pair 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromosomes, Human, Pair 19", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Situ Hybridization, Fluorescence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oligodendroglioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Seattle Cancer Care Alliance", 
          "id": "https://www.grid.ac/institutes/grid.430269.a", 
          "name": [
            "Department of Neurology, University of Washington, Seattle, WA, USA", 
            "University of Washington/Fred Hutchison Cancer Research Center, Seattle Cancer Care Alliance, 825 Eastlake Ave E, POB 19023, MS G4940, 98109, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chamberlain", 
        "givenName": "Marc C.", 
        "id": "sg:person.01326261166.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lucile Packard Children's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414123.1", 
          "name": [
            "Department of Pathology-Neuropathology, Stanford University, Palo Alto, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Born", 
        "givenName": "Donald", 
        "id": "sg:person.01013752502.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013752502.14"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/neuonc/nou237.13", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006806579"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-09-0867", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007696783"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.43.2229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011620673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/not092", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018211351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnen/63.4.314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019189688"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/90.19.1473", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020269354"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-1796", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021577504"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrneurol.2013.268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022780102", 
          "https://doi.org/10.1038/nrneurol.2013.268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-014-1526-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028481314", 
          "https://doi.org/10.1007/s11060-014-1526-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/nen.0b013e31825b5f7a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038739236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.43.2674", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044364683"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-11", 
    "datePublishedReg": "2015-11-01", 
    "description": "1p/19q codeletion is a favorable prognostic marker for oligodendroglial tumors (OT). Compare outcome in OT with simple deletions of 1p or 19q to those with relative deletions defined as the presence of both increased copy number (polysomy) and 1p/19q codeletion. 525 cases were examined by fluorescence in situ hybridization (FISH) using dual color probes to determine the deletion status of chromosome arms 1p and 19q. Categories included simple deletions defined as a proportion of either 1p32 or 19q13 FISH signals compared to 1q42 or 19p13 signals less than 0.80 and relative deletions (1p or 19q) defined as the combination of a <0.80 proportion with >30 % of nuclei showing increased chromosome number (based on enumeration of 1q25 or 19p13). 464 (80 %) were WHO Grade II or III OT of which 209 (48 %) had both 1p and 19q deleted (codeletion). 72 (16 %) had relative deletions for either one or both 1p and 19q of which 28 (6 %) had relative deletions of 1p and 19q (relative codeletion). Overall survival in WHO Grade II OT was 13 + years when 1p/19q codeleted (n = 156); 5 + years in uni- or nondeleted (n = 86); 6 + years in relative deletion for either 1p or 19q (n = 41); and 6 + years in relative 1p/19q codeletion (n = 15). Similarly in WHO Grade III OT (n = 168) overall survival was 11 + years in 1p/19q codeleted (n = 54) OT; 2.5 years in uni- or nondeleted (n = 70); 3 years in relative deletion for one or both 1p or 19q (n = 31); and 4 + years in relative 1p/19q codeletion (n = 13). Survival for OT regardless of grade with relative codeletion of 1p/19q was approximately one half that of 1p/19q codeleted tumors. The presence of relative 1p/19q codeletion is of prognostic significance.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-015-1906-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "125"
      }
    ], 
    "name": "Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors", 
    "pagination": "249-251", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "2c2cafb4c708ea62195b5c30613d1409350b2be0299d2d4d93e5c258432c45b3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26341371"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-015-1906-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009273335"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-015-1906-y", 
      "https://app.dimensions.ai/details/publication/pub.1009273335"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T20:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000530.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-015-1906-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1906-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1906-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1906-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-015-1906-y'


 

This table displays all metadata directly associated to this object as RDF triples.

155 TRIPLES      21 PREDICATES      50 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-015-1906-y schema:about N249f6c61a36d46f18f691bf7c7920810
2 N3815ba1d3dba4c9e9edabd84cae6014b
3 N440cd8f19b4b4238a760ac9d317edd0a
4 N57a3fd158a37442aa5b8bd3c22a68b1b
5 N7ba1ec9baa7f484591301ec9d8b033b5
6 N8cf49190a1344ca191e31597e939cf46
7 N901bbf9ad0fa4f3390bbb4640048fa43
8 Nc783c1a24e4843dea6b4e824f60f1570
9 Nddfb3f10de7a41faa28133e3dd9b69bb
10 Neb8eb51bbac34d76808f880ebcba5288
11 anzsrc-for:11
12 anzsrc-for:1112
13 schema:author N2a59656e71364ea1b1f8923c72348718
14 schema:citation sg:pub.10.1007/s11060-014-1526-y
15 sg:pub.10.1038/nrneurol.2013.268
16 https://doi.org/10.1093/jnci/90.19.1473
17 https://doi.org/10.1093/jnen/63.4.314
18 https://doi.org/10.1093/neuonc/not092
19 https://doi.org/10.1093/neuonc/nou237.13
20 https://doi.org/10.1097/nen.0b013e31825b5f7a
21 https://doi.org/10.1158/0008-5472.can-06-1796
22 https://doi.org/10.1158/1078-0432.ccr-09-0867
23 https://doi.org/10.1200/jco.2012.43.2229
24 https://doi.org/10.1200/jco.2012.43.2674
25 schema:datePublished 2015-11
26 schema:datePublishedReg 2015-11-01
27 schema:description 1p/19q codeletion is a favorable prognostic marker for oligodendroglial tumors (OT). Compare outcome in OT with simple deletions of 1p or 19q to those with relative deletions defined as the presence of both increased copy number (polysomy) and 1p/19q codeletion. 525 cases were examined by fluorescence in situ hybridization (FISH) using dual color probes to determine the deletion status of chromosome arms 1p and 19q. Categories included simple deletions defined as a proportion of either 1p32 or 19q13 FISH signals compared to 1q42 or 19p13 signals less than 0.80 and relative deletions (1p or 19q) defined as the combination of a <0.80 proportion with >30 % of nuclei showing increased chromosome number (based on enumeration of 1q25 or 19p13). 464 (80 %) were WHO Grade II or III OT of which 209 (48 %) had both 1p and 19q deleted (codeletion). 72 (16 %) had relative deletions for either one or both 1p and 19q of which 28 (6 %) had relative deletions of 1p and 19q (relative codeletion). Overall survival in WHO Grade II OT was 13 + years when 1p/19q codeleted (n = 156); 5 + years in uni- or nondeleted (n = 86); 6 + years in relative deletion for either 1p or 19q (n = 41); and 6 + years in relative 1p/19q codeletion (n = 15). Similarly in WHO Grade III OT (n = 168) overall survival was 11 + years in 1p/19q codeleted (n = 54) OT; 2.5 years in uni- or nondeleted (n = 70); 3 years in relative deletion for one or both 1p or 19q (n = 31); and 4 + years in relative 1p/19q codeletion (n = 13). Survival for OT regardless of grade with relative codeletion of 1p/19q was approximately one half that of 1p/19q codeleted tumors. The presence of relative 1p/19q codeletion is of prognostic significance.
28 schema:genre research_article
29 schema:inLanguage en
30 schema:isAccessibleForFree false
31 schema:isPartOf N0a8fc4e650564bc9b3d95e03880d7459
32 Na0fb7011d954416fa9f3b47fd115d51b
33 sg:journal.1094205
34 schema:name Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors
35 schema:pagination 249-251
36 schema:productId N31907ea1edf148ee914296e8aeda7f97
37 N49cf25d68f564af68fa16e195688d647
38 N904599f1fe6c4452afec89673108552e
39 N99545afabcde4e6da454fad4081f4ce3
40 Nb65d15989b78429594a962100de6c566
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009273335
42 https://doi.org/10.1007/s11060-015-1906-y
43 schema:sdDatePublished 2019-04-10T20:00
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N17f00a6a6fe849f4be763eeb7ff2e082
46 schema:url http://link.springer.com/10.1007%2Fs11060-015-1906-y
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N0a8fc4e650564bc9b3d95e03880d7459 schema:volumeNumber 125
51 rdf:type schema:PublicationVolume
52 N17f00a6a6fe849f4be763eeb7ff2e082 schema:name Springer Nature - SN SciGraph project
53 rdf:type schema:Organization
54 N249f6c61a36d46f18f691bf7c7920810 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name In Situ Hybridization, Fluorescence
56 rdf:type schema:DefinedTerm
57 N2a59656e71364ea1b1f8923c72348718 rdf:first sg:person.01326261166.36
58 rdf:rest N36628bd3b3b9483eb9d1ac3c1bbe3cf2
59 N31907ea1edf148ee914296e8aeda7f97 schema:name nlm_unique_id
60 schema:value 8309335
61 rdf:type schema:PropertyValue
62 N36628bd3b3b9483eb9d1ac3c1bbe3cf2 rdf:first sg:person.01013752502.14
63 rdf:rest rdf:nil
64 N3815ba1d3dba4c9e9edabd84cae6014b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Female
66 rdf:type schema:DefinedTerm
67 N440cd8f19b4b4238a760ac9d317edd0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Humans
69 rdf:type schema:DefinedTerm
70 N49cf25d68f564af68fa16e195688d647 schema:name dimensions_id
71 schema:value pub.1009273335
72 rdf:type schema:PropertyValue
73 N57a3fd158a37442aa5b8bd3c22a68b1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Male
75 rdf:type schema:DefinedTerm
76 N7ba1ec9baa7f484591301ec9d8b033b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Prognosis
78 rdf:type schema:DefinedTerm
79 N8cf49190a1344ca191e31597e939cf46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Chromosomes, Human, Pair 19
81 rdf:type schema:DefinedTerm
82 N901bbf9ad0fa4f3390bbb4640048fa43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Chromosome Deletion
84 rdf:type schema:DefinedTerm
85 N904599f1fe6c4452afec89673108552e schema:name readcube_id
86 schema:value 2c2cafb4c708ea62195b5c30613d1409350b2be0299d2d4d93e5c258432c45b3
87 rdf:type schema:PropertyValue
88 N99545afabcde4e6da454fad4081f4ce3 schema:name doi
89 schema:value 10.1007/s11060-015-1906-y
90 rdf:type schema:PropertyValue
91 Na0fb7011d954416fa9f3b47fd115d51b schema:issueNumber 2
92 rdf:type schema:PublicationIssue
93 Nb65d15989b78429594a962100de6c566 schema:name pubmed_id
94 schema:value 26341371
95 rdf:type schema:PropertyValue
96 Nc783c1a24e4843dea6b4e824f60f1570 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Brain Neoplasms
98 rdf:type schema:DefinedTerm
99 Nddfb3f10de7a41faa28133e3dd9b69bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Chromosomes, Human, Pair 1
101 rdf:type schema:DefinedTerm
102 Neb8eb51bbac34d76808f880ebcba5288 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Oligodendroglioma
104 rdf:type schema:DefinedTerm
105 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
106 schema:name Medical and Health Sciences
107 rdf:type schema:DefinedTerm
108 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
109 schema:name Oncology and Carcinogenesis
110 rdf:type schema:DefinedTerm
111 sg:journal.1094205 schema:issn 0167-594X
112 1573-7373
113 schema:name Journal of Neuro-Oncology
114 rdf:type schema:Periodical
115 sg:person.01013752502.14 schema:affiliation https://www.grid.ac/institutes/grid.414123.1
116 schema:familyName Born
117 schema:givenName Donald
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013752502.14
119 rdf:type schema:Person
120 sg:person.01326261166.36 schema:affiliation https://www.grid.ac/institutes/grid.430269.a
121 schema:familyName Chamberlain
122 schema:givenName Marc C.
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36
124 rdf:type schema:Person
125 sg:pub.10.1007/s11060-014-1526-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1028481314
126 https://doi.org/10.1007/s11060-014-1526-y
127 rdf:type schema:CreativeWork
128 sg:pub.10.1038/nrneurol.2013.268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022780102
129 https://doi.org/10.1038/nrneurol.2013.268
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1093/jnci/90.19.1473 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020269354
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1093/jnen/63.4.314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019189688
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1093/neuonc/not092 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018211351
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1093/neuonc/nou237.13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006806579
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1097/nen.0b013e31825b5f7a schema:sameAs https://app.dimensions.ai/details/publication/pub.1038739236
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1158/0008-5472.can-06-1796 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021577504
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1158/1078-0432.ccr-09-0867 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007696783
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1200/jco.2012.43.2229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011620673
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1200/jco.2012.43.2674 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044364683
148 rdf:type schema:CreativeWork
149 https://www.grid.ac/institutes/grid.414123.1 schema:alternateName Lucile Packard Children's Hospital
150 schema:name Department of Pathology-Neuropathology, Stanford University, Palo Alto, CA, USA
151 rdf:type schema:Organization
152 https://www.grid.ac/institutes/grid.430269.a schema:alternateName Seattle Cancer Care Alliance
153 schema:name Department of Neurology, University of Washington, Seattle, WA, USA
154 University of Washington/Fred Hutchison Cancer Research Center, Seattle Cancer Care Alliance, 825 Eastlake Ave E, POB 19023, MS G4940, 98109, Seattle, WA, USA
155 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...